Ethan Daniel Miller, MD

Peer-Reviewed Articles

1. Yibirin M, Mustafayev K, Hosry J, Pundhir P, Klingen J, Guevara EY, Granwehr BP, Kaseb A, Naing A, Patel S, Shah AY, Skoulidis F, Tawbi HA, Wang L, Miller E, Zhang HC, Zurita-Saavedra A, Torres HA. Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors. Am J Gastroenterol 118(9):1609 - 1617, 2023. e-Pub 2023. PMID: 37307533.
2. Nardo, M, Yilmaz, B, Nelson, BE, Torres HA, Wang LS, BPalma G, Song J, Dalla Pria HRF, Trinh VA, Glitza Oliva IC, Patel SP, Tannir NM, AOmar K, Altan M, Lee SS, Miller E, Zhang HC, Stephen BA, Naing A. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience. Oncologist 28(8):714 - 721, 2023. e-Pub 2023. PMID: 36952233.
3. Zhang HC, Miller ED, Wang L. Early Use of Tocilizumab as an Effective Steroid-Sparing Strategy for the Treatment of Immune Checkpoint Inhibitor-Mediated Cholangiopathy: Building Foundations for Personalized Management. Zhang HC, Miller ED, Wang L 117(10S):e1931, 2022. e-Pub 2022.
4. Pritchard H, Hwang JP, Angelidakis G, Yibirin M, Wang L, Miller ED, Torres HA. Hepatitis B Virus Reactivation in Cancer Patients Receiving Direct-Acting Antivirals for Hepatitis C Virus Infection. J Viral Hepat 28(5):844-848, 2021. e-Pub 2021. PMID: 33523503.
5. Eyada M, Taggart MW, Wang LS, Miller ED, Zhang HC. Diagnosis and characteristics of immune checkpoint inhibitor-mediated cholangiopathy: a case series 160(6):S851-2, 2021. e-Pub 2021. PMID: 8108234.
6. Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Kaseb A, Miller ED, Sturgis EM, Foreman JT, Angelidakis G, Ahmed S, Ferrajoli A, Samaniego F, Hawk ET, Hwang JP. Strategies to Identify Hepatitis C Virus Infection in Patients Receiving Anticancer Therapy: A Cross-Sectional Study. Support Care Cancer 29(1):05456-3, 2021. e-Pub 2021. PMID: 32314052.
7. Regev A, Avigan MI, Kiazand A, Vierling JM, Lewis JH, Omokaro SO, Di Bisceglie AM, Fontana RJ, Bonkovsky HL, Freston JW, Uetrecht JP, Miller ED, Pehlivanov ND, Haque SA, Harrison MJ, Kullak-Ublick GA, Li H, Patel NN, Patwardhan M, Price KD, Watkins PB, Chalasani NP. Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development. J Autoimmun 114, 2020. e-Pub 2020. PMID: 32768244.
8. Pomenti S, Gandle C, Abu Sbeih H, Phipps M, Livanos A, Guo A, Yeh J, Burney H, Liu H, Kakhoul L, Kettler C, Gawrieh S, DeLemos A, Scanga A, Chalasani N, Miller E, Wattacheril J. Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort. Hepat Comm 4(11):1708 - 1716, 2020. e-Pub 2020.
9. Hill A, Elakkad A, Kuban J, Sabir S, Odisio B, Huang SY, Mahvash A, Miller ED, Kroll MH, Overman M, Tam AL, Gupta S, Sheth RA. Durability of partial splenic artery embolization on platelet counts for cancer patients with hypersplenism-related thrombocytopenia. Abdominal Radiology 45(9):2886-2894, 2020. e-Pub 2020. PMID: 32314004.
10. Sydney Pomenti S, Gandle C, Abu-Sbeih H, Phipps M, Livanos A, Guo A, Yeh J, Burney H, Liu H, Dakhoul L, Kettler C, Gawrieh S, DeLemos A, Scanga A, Chalasani N, Miller ED, Wattacheril J. Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort. Hepatology Communications 4(11):1708-1716, 2020. e-Pub 2020. PMID: 33163839.
11. Chalasani, NP, Gawrieh S, DeLemos AS, Miller ED, Scanga AE, Burney HN, Wattacheril J. Gender Matters: Characteristics of Hepatocellular Carcinoma in Women from a Large, Multicenter Study in the United States. Amer Journal Gastroenterology, 2020. e-Pub 2020. PMID: 32453046.
12. DeLemos A, Patel M, Gawrieh S, Burney H, Dakhoul L, Miller ED, Scanga A, Kettler C, Liu H, Roche P, Wattacheril J, Chalasani N. Distinctive features and outcomes of hepatocellular carcinoma (HCC) in patients with alcohol-related liver disease: A US multicenter study. Clin Transl Gastroenterol 11(3), 2020. e-Pub 2020. PMID: 32352723.
13. Raju GS, Lum P, Abu-Sbeih H, Ross WA, Thirumurthi S, Miller ED, Lynch P, Lee J, Bhutani MS, Shafi M, Weston B, Rashid A, Wang Y, Chang GJ, Carlson R, Hagan K, Davila M, Stroehlein J. Cap-fitted endoscopic mucosal resection of =?20?mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate. Endosc Int Open 8(2):E115-E121, 2020. e-Pub 2020. PMID: 32010742.
14. Miller ED, Abu-Sbeih H, Styskel B, Nogueras Gonzalez GM, Blechacz B, Naing A, Chalasani N. Clinical characteristics and adverse impact of hepatotoxicity due to immune checkpoint inhibitors. Am J Gastroenterol 115(2):251-261, 2020. e-Pub 2020. PMID: 31789632.
15. Stephen B, Hajjar J. Overview of Basic Immunology and Clinical Application. Adv Exp Med Biol(1244):1-36, 2020. e-Pub 2020. PMID: 32301008.
16. Gawrieh S, Dakhoul L, Miller E, Scanga A, DeLemos A, Kettler C, Burney H, Liu H, Abu-Sbeih H, Chalasani N, Wattacheril J. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study. Alimentary Pharmacology & Therapeutics 50(7):809-821, 2019. e-Pub 2019. PMID: 31475372.
17. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20mm colon polyps. Endosc Int Open 7(3):E361-E366, 2019. e-Pub 2019. PMID: 30834295.
18. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20mm colon polyps. Endosc Int Open 7(3):E361-E366, 2019. e-Pub 2019. PMID: 30834295.
19. Torres HA, Economides MP, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P, Jiang Y, Miller E, Blechacz B, Naing A, Samaniego F, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-based therapy in hepatitis C virus-infected cancer patients: A prospective observational study. Am J Gastroentrol 114(2):250-527, 2019. e-Pub 2019. PMID: 30410039.
20. Hwang JP, Lok MJ, Fisch SB, Cantor AB, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller ED, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME. Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anti-Cancer Therapy: A Prospective Cohort Study. Journal of Clinical Oncology 36(10):959-967, 2018. e-Pub 2018. PMID: 6114061.
21. Torres HA, Roach LR, Mahale P, Economides MP, Blechacz B, Miller ED, Borchardt R, Rashid A, Oo TH, Shukla B, Farida M, Ericsson CD, Granwehr BP, Raad II. Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center. J Natl Compr Canc Netw 14(9):1185-8, 2016. e-Pub 2016. PMID: 27587628.
22. Raju GS, Lum PJ, Ross WA, Thirumurthi S, Miller ED, Lynch PM, Lee JH, Bhutani MS, Shafi MA, Weston BR, Pande M, Bresalier RS, Rashid A, Mishra L, Davila MD, Stroehlein JR. Outcome of EMR as alternative to surgery in patients with complex colon polyps. Gastrointest Endosc 84(2):315-25, 2016. e-Pub 2016. PMID: 26859866.
23. Torres HA, Mahale P, Miller ED, Frenette C. Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: as case series. J Hepatocell Carcinoma(1):109-14, 2016. e-Pub 2016. PMID: 27508180.
24. Raju GS, Lum P, Slack RS, Thirumurthi S, Lynch PM, Miller ED, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR. Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc 82(3):512-9, 2015. e-Pub 2015. PMID: 25910665.
25. Torres HA, Mahale P, Blechacz B, Miller ED, Kaseb A, Herlong HF, Fowler N, Jiang Y, Raad II, Kontoyiannis DP. Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Network 13(1):41-50, 2015. e-Pub 2015. PMID: 25583768.
26. Torres HA, Kaseb A, Mahale P, Miller ED, Frenette C. Telaprevir-containing regimen for treatment of hepatitis C virus infection in patient with hepatocellular carcinoma waiting liver transplantation: a case series. Journal of Hepatocellular Carcinoma 1:109-114, 2014. e-Pub 2014. PMID: 27508180.
27. Torres HA, Mahale P, Miller ED, Oo TH, Frenette C, Kaseb AO. Co-administration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma. World J Hepatol 5(6):332-5, 2013. e-Pub 2013. PMID: 23805358.
28. Islam S, Miller ED, Patel N, De Petris G, Highsmith EW, Fleischer DE. The use of DNA fingerprinting to resolve conflicting results in patients with suspected gastrointestinal malignancy. J Clin Gastroenterol 47(3):239-41, 2013. e-Pub 2013. PMID: 23391868.
29. Miller ED, Steidley DE, Arabia FA, Decker GA. Gastric erosion associated with left ventricular assist device: new technology, new complication. Gastrointest Endosc 70(1):181-3, 2009. e-Pub 2009. PMID: 19152894.
30. Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther 27(3):274-82, 2008. e-Pub 2008. PMID: 17996017.
31. Wong WT, Myhr KL, Miller ED, Wong RO. Developmental changes in the neurotransmitter regulation of correlated spontaneous retinal activity. J Neurosci 20(1):351-60, 2000. e-Pub 2000. PMID: 10627612.
32. Miller ED, Tran MN, Wong GK, Oakley DM, Wong RO. Morphological differentiation of bipolar cells in the ferret retina. Vis Neurosci 16(6):1133-44, 1999. e-Pub 1999. PMID: 10614593.

Abstracts

1. Machado AP, Caskey KN, Shaikh AS, Wang L, Miller ED, Wang Y, Zhang HC. Oral Budesonide for the Treatment of Immune Checkpoint Inhibitor-Mediated Hepatobiliary Toxicities: A Case Series. Digestive Disease Week (DDW) 2025, 2025. e-Pub 2025.
2. Kuang A, Carlson K, Zhang HC, Wang L, Miller E. Immune-Mediated Cholangiopathic Toxicity: A Case of Immunotherapy-Related Sclerosing Cholangitis, 2023. e-Pub 2023.
3. Zhang HC, Miller ED, Wang L. Early Use of Tocilizumab as an Effective Steroid-Sparing Strategy for the Treatment of Immune Checkpoint Inhibitor-Mediated Cholangiopathy: Building Foundations for Personalized Management. ACG Annual Meeting, 2022. e-Pub 2022.
4. Zhang HC, Miller ED, Wang L. Tocilizumab as an Effective Steroid-Sparing Agent for the Treatment of Recurrent and Steroid-Dependent Immune Checkpoint Inhibitor-Mediated Hepatotoxicity: A Case Study and Insight into Pathophysiology 117(10S):e1896 - e1897, 2022. e-Pub 2022.
5. Zhang HC, Taggart M, Miller ED, Fossella F, Wang LS. Extrahepatic Biliary Sequelae in Immune Checkpoint Inhibitor-Mediated Cholangiohepatitis: Urgent Unmet Need for Early Effective Treatment. ACG Annual Meeting 116(P):S1139, 2021. e-Pub 2021.
6. Zhang HC, Wang LS, Wang Y, Miller ED. Budesonide as an Alternative Steroid Agent, in Combination with Adjunctive Agents, for the Treatment of Immune Checkpoint Inhibitor-Mediated Cholangiohepatitis: A Case Study. Am J Gastroenterol 116(P):S1139, 2021. e-Pub 2021.
7. Zhang HC, Eyada M, Taggart M, Miller ED, Negrao M, Varghese S, Wang LS. Clinical Presentation, Treatment Strategies, and Chronic Sequelae of Immune Checkpoint Inhibitor-Mediated Cholangiopathy: A Case Study. ACG Annual Meeting 116(P):1140, 2021. e-Pub 2021.
8. Zhang, HC, Eyada, M, Miller, ED, Wang, LS. Tocilizumab as an alternative treatment strategy for immunotherapy-mediated hepatobiliary toxicity: addressing an urgent unmet need, 2021. e-Pub 2021.
9. Eyada M, Taggart MW, Wang LS, Miller ED, Zhang HC. Diagnosis and characteristics of immune checkpoint inhibitor-mediated cholangiopathy: a case series, 2021. e-Pub 2021.
10. Wang LS, Zhang HC, Miller ED. Moderate Dose Steroid Treatment for Immune Checkpoint Inhibitor-Mediated Hepatotoxicity. Gastroenterology 160(6):S790, 2021. e-Pub 2021.
11. Zhang HC, Miller ED, Wang L. Tocilizumab as an Effective Steroid-Sparing Agent for the Treatment of Recurrent and Steroid-Dependent Immune Checkpoint Inhibitor-Mediated Hepatotoxicity: A Case Study and Insight into Pathophysiology. DDW Annual Meeting, 2021. e-Pub 2021.
12. Yibirin M, Pundhir P, Yepez-Guevara E, Granwehr BP, Kaseb A, Patel S, Naing A, Shah AY, Skoulidis F, Tawbi HA, Zhang HC, Wang L, Miller ED, Torres HA. Safety of Immune Checkpoint Inhibitors in Cancer Patients with Chronic Hepatitis C Infection: A Prospective Observational Study. Poster presented at The Liver Meeting 2020, 2020. e-Pub 2020.
13. DeLemos A, Patel M, Gawrieh S, Burney H, Dakhoul L, Miller ED, Scanga A, Kettler C, Liu H, Roche P, Wattacheril J, Chalasani N. Distinctive features and outcomes of hepatocellular carcinoma (HCC) in patients with alcohol-related liver disease: A UNITED STATES MULTICENTER STUDY 11(3):e00139, 2020. e-Pub 2020. PMID: 32352723.
14. Raghavendra A, Barcenas CH, Hwang H, Wang X, Eke C, Avirineni A, Abu-Sbein H, Garg N, Lum P, Miller E. Clinical significance of elevated liver enzymes after exposure to endocrine therapy in early-stage breast cancer patients, 2019. e-Pub 2019.
15. Ferson D, Hagan K, Miller E, Carlson R, Zavala M, Winter E, Rahlfs T. Emergency airway management with the LMA during upper endoscopy in a patient with difficult-to-manage airway, 2019. e-Pub 2019.
16. Phipps M, Livanos A, Guo A, Pomenti S, Yeh J, Dakhoul L, Burney H, Kettler C, Liu H, Miller ED, Gawrieh S, DeLemos AS, Scanga A, Chalasani NP, Wattacheril J. Distinct characteristics of hepatocellular carcinoma in women: Results from a large, Multicenter study in the United State, 2019. e-Pub 2019.
17. Torres HA, Economides MP, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P, Jiang Y, Miller E, Blechacz B, Naing A, Samaniego F, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-based therapy in hepatitis C virus-infected cancer patients: A prospective observational study 114(2):250-257, 2019. e-Pub 2019. PMID: 30410039.
18. Abu-Sbeih H, Styskel B, Blechacz B, Chalasani N, Miller ED. Clinically Significant Hepatotoxicity Due to Immune Checkpoint Inhibitors Is Rare but Leads to Treatment Discontinuation in a High Proportion, 2018. e-Pub 2018.
19. DeLemos A, Dakhoul L, Miller ED, Wattacheril J, Scanga A, Roche P, Abu Sbeih H, Mao E, Gomez EV, Gawrieh S, Chalasani N. Nonalcoholic fatty liver disease is the most common Cause of hepatocellular carcinoma (HCC) in individuals without cirrhosis: A United States multicenter study, 2018. e-Pub 2018.
20. Miller ED, Dakhoul L, Abu Sbeih H, Mao E, DeLemos A, Roche P, Scanga A, Vilar Gomez E, Gawrieh S, Chalasani N, Wattacheril J. Increasing trend for hepatocellular carcinoma (HCC) linked to nonalcoholic fatty liver disease (NAFLD) in the United States, 2018. e-Pub 2018.
21. Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Miller ED, Kaseb A, Sturgis E, Angelidakis G, Ahmed S, Ferrajoli A, Samaniego F, Hawk E, Hwang JP. Hepatitis C virus risk tool for patients with cancer, 2018. e-Pub 2018.
22. Zhang HC, Dedania BK, Miller ED. Adverse Hepatobiliary Effects of Pegaspargase: Diagnostic Features and Potential Treatment, 2017. e-Pub 2017.
23. Dedania BK, Zhang HC, Miller ED. Everolimus-induced Hypertriglyceridemia Manifesting as Acute Pancreatitis, 2017. e-Pub 2017.
24. Alshawa A, Fujii T, Abu Sbeih H, Blechacz B, Bilen AM, Hess KR, Suarez-Almazor ME, Hong DS, Tsimberidou A, Gong J, Stephen B, Subbiah V, Piha-Paul SA, Fu S, Mendoza T, Thirumurthi S, Meric-Bernstam F, Naing A, Miller ED. Hepatotoxicity in advanced cancer patients receiving immune-based cancer treatment, 2017. e-Pub 2017.
25. DaVee T, Deep A, Khuwaja S, Thirumurthi S, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Miller ED, Lee JH. Does prior abdominal surgery increase the incidence of adverse events following percutaneous endoscopic gastrostomy tube placement 152(5):S417, 2017. e-Pub 2017.
26. Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo AG, Lin HY, Foreman JT, Vierling JM, Torres H, Granwehn B, Miller ED, Saurez-Almazor M. Predicting Hepatitis B Virus Infection among Patients with Cancer Undergoing Systemic Anti-cancer Therapy: A Prospective Cohort Study. 40th Annual Meeting of the Society of General Internal Medicine 32:S280, 2017. e-Pub 2017.
27. Raju GS, Lum P, Ross W, Lynch PM, Thirumurthi S, Miller ED, Blechacz B, Weston BR, Shafi M, Bhutani MS. Better management of patients with large colon polyps requires improvement in the knowledge gaps among referring endoscopists. Presented at Digestive Disease Week, May 6-9,2017,Chicago,IL 85(5):AB545-546, 2017. e-Pub 2017.
28. Raju GS, Lum P, Ross W, Lynch PM, Miller ED, Thirumurthi S, Blechacz B, Lee JH, Shafi M, Bhutani MS, Asif R, Weston BR, Davila ML, Stroehlein JR. Outcome of a Protocol Driven Endoscopic Resection of patients with large colon polyps (<20mm) results in low complications and recurrence, 2016. e-Pub 2016.
29. Torres HA, Mahale P, Granwehr B, Miller ED, Borchardt R, Shukla B, Ericsson CD, RaadII. Transdisciplinary approach to managing HCV infection in patients at a tertiary care center Accepted for poster presentation at the 2015 ID Week, 10/7-11/20, 2015. e-Pub 2015.
30. ED| M, Thirumurthi S, Lum P, Pande M, Ross WA, Davila MA, Weston BR, Blechacz B, Bhutani MS, Lee J, Lynch PM, Shafi MA, Bresalier RS, Mishra L, Stroehlein JR, Raju GS. Five-Year Trends in Adenoma Detection Rates: a Report From a Single Academic Group Practice. Digestive Disease Week (DDW) 81(5):AB213, 2015. e-Pub 2015.
31. Thirumurthi S, Ross WA, Lum P, Pande M, Miller E, Lee J, Weston BR, Lynch PM, Davila ML, Bhutani MS. When patients watch a video, physicians see more adenomas: an educational bowel preparation video improves adenoma detection rates. Gastrointest Endosc 81((5) Suppl):AB228-229, 2015. e-Pub 2015.
32. Patham B, Miller ED, Murphy WA, I-Nan Hu M. Tenofovir-Related Hypophosphatemic Ostemomalacia and Multiple Fractures Mimicking Metastatic Bone Disease in a Patient with Hepatocellular Carcinoma San Diego, CA, 2015. e-Pub 2015.
33. Raju GS, Lum P, Serna MK, Ross WA, Davila ML, Lynch PM, Thirumurthi S, Lee J, Miller ED, Bhutani MS. Outcome of Referral to an Endoscopic Mucosal Resection Center As an Alternative to Surgery in Patients With Large and Flat Colon Tumors. 1062. Presented at Digestive Disease Week May 16-19, 2015, Washington,DC 81(5):AB195-96, 2015. e-Pub 2015.
34. Weston BR, Ross WA, Lum P, Thirumurthi S, Miller ED, Bhutani MS, Blechacz B, Bresalier RS, Davila ML, Dekovich AA, Guha S, Lee JH, Lynch PM, Pande M, Asif R, Shafi MA, Shuttlesworth G, Stack RS, Mishra L, Stroehlein JR, Raju GS. Adenoma detection rate (ADR) and serrated adenoma detection rate (SDR) during screening colonoscopy with and without a personal cancer history (PCH) in a tertiary referral cancer center. DDW 79(5):AB202, 2014. e-Pub 2014.
35. Miller ED, Ross WA, Lum P, Thirumurthi S, Weston BR, Pande M, et al. Screening Colonoscopy Quality Metrics for Males and Females Across Ethnic Groups Using a Natural Language Processing Algorithm. Poster DDW 2014. Gastrointestinal Endoscopy 79(5S):Sa1409, 2014. e-Pub 2014.
36. Raju G, Ross WA, Lum P, Lynch PM, Slack RS, et al ME. Natural Language Processing (NLP) As an Alternative to Manual Reporting of Colonoscopy Quality Metrics 79(5S, 166,):AB116-AB117, 2014. e-Pub 2014.
37. Lum P, Ross WA, Pande M, Lynch PM, Miller ED, et al. Measures to Improve Colonoscopy Quality Metrics. Poster DDW 2014 Gastrointestinal Endoscopy 79(5S):Sa1409, 2014. e-Pub 2014.
38. Miller ED, Blechacz B, Herlong HF, Davila M, Torres HA. The effect of antiviral therapy on progression of liver disease in Hepatitis C Virus-infected patients with malignancies AASLD's 64th Annual Meeting in Washington, DC, November 1 - Nove, 2013. e-Pub 2013.
39. Torres HA, Davila M, Mulanovich VE, Granwehr BP, Miller ED, Nevah MI, Mishra L, Kontoyiannis DP. Hepatitis C Clinic at a Comprehensive Cancer Center: The successful story of multidisciplinary efforts Accepted for poster presentation at the 49th IDSA Annual Meeting, 2011. e-Pub 2011.
40. Decker GA, Miller ED, Pasha SF, Harrison ME, Leighton JA. Deep enteroscopy in patients with left ventricular assist devices: practical and technical considerations 42(2):E194, 2010. e-Pub 2010. PMID: 20845267.
41. Miller ED, Steidley D, Arabia F, Das A, Crowell M, Leighton J, Decker A. Gastrointestinal complications associated with left ventricular assist devices. Am J Gastroenterol 103(Suppl S):S521-2, 2008. e-Pub 2008. PMID: 20845267.
42. Miller ED, Hampel H, Goodgame RW. A novel mutation involving an insertion in exon 4 of the APC gene leading to an uncommon phenotype: A 62 year-old man with synchronous colon cancers and 175 adenomas. Am J Gastroenterol 99(10):S350, 2004. e-Pub 2004.
43. Wong WT, Myhr KL, Miller ED, Wong ROL. Developmental changes in the neurotransmitter regulation of correlated spontaneous retinal activity 20(1):351-360, 2000. e-Pub 2000. PMID: 10627612.
44. Miller ED, Wong GK, Oakley DM, Wong ROL. Morphological and functional development of bipolar cells in the ferret retina 23:641, 1997. e-Pub 1997.

Book Chapters

1. Zhang, HC, Miller, E, Wang, L, Shah, JS, Rashid, A, Msaouel, P. Immune Checkpoint Inhibitor-Mediated Hepatotoxicity, 267-276, 2025.
2. Zhang, HC, Miller, E, Wang, L, Rivera, AU, Chun, YS, Ledet, CR. Cholangiohepatitis with Extrahepatic Cholangiopathy and Cholecystitis Secondary to Immune Checkpoint Inhibitor Therapy, 257-265, 2025.
3. Zhang, HC, Miller, E, Wang, L, Ngo, S, Chatterjee, D, Zurita-Saavedra, A. Hepatobiliary Toxicity Secondary to Immune Checkpoint Inhibitor Therapy, 243-255, 2025.
4. Zhang HC, Wang LS, MIller ED. Hepatology (Liver and Bile Duct). In: Managing Immunotherapy Related Organ Toxicities. 1st Edition. Springer International Publishing, 119-165, 2022.
5. Zhang HC, Wang LS, Miller E. Hepatobiliary and Pancreatic Adverse Events. In: Advance in Experimental Medicine and Biology. Springer, 339-355, 2021.
6. Miller ED, Abu-Sbeih H, Chalasani NP. Drug-Induced Liver Injury in Older Adults in Geriatric Gastroenterology. In: Geriatric Gastroenterology. Second Edition. Springer International, 1391 - 1406, 2021.
7. Miller ED, Harrison MEH. Gallstones, Gallbladder Polyps and Their Complications: Epidemiology, Pathogenesis, Diagnosis, and Management. In: Practical Gastroenterology and Hepatology. Oxford Blackwell, 2010.
8. Wong ROL, Miller ED, Wong WT, Shields CR, Cyhr KL. Development changes in the spontaneous bursting patterns of on and off ganglion cells. In: Development and Organization of the Retina: From Molecules to Function. Plenum Press, 275-88, 1998.